全文获取类型
收费全文 | 4792篇 |
免费 | 323篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 114篇 |
妇产科学 | 45篇 |
基础医学 | 576篇 |
口腔科学 | 121篇 |
临床医学 | 423篇 |
内科学 | 1342篇 |
皮肤病学 | 31篇 |
神经病学 | 324篇 |
特种医学 | 207篇 |
外科学 | 809篇 |
综合类 | 23篇 |
一般理论 | 1篇 |
预防医学 | 124篇 |
眼科学 | 154篇 |
药学 | 249篇 |
中国医学 | 3篇 |
肿瘤学 | 522篇 |
出版年
2024年 | 11篇 |
2023年 | 99篇 |
2022年 | 177篇 |
2021年 | 315篇 |
2020年 | 152篇 |
2019年 | 168篇 |
2018年 | 191篇 |
2017年 | 146篇 |
2016年 | 179篇 |
2015年 | 156篇 |
2014年 | 174篇 |
2013年 | 239篇 |
2012年 | 369篇 |
2011年 | 418篇 |
2010年 | 201篇 |
2009年 | 139篇 |
2008年 | 237篇 |
2007年 | 244篇 |
2006年 | 203篇 |
2005年 | 199篇 |
2004年 | 170篇 |
2003年 | 172篇 |
2002年 | 161篇 |
2001年 | 24篇 |
2000年 | 32篇 |
1999年 | 37篇 |
1998年 | 32篇 |
1997年 | 26篇 |
1996年 | 28篇 |
1995年 | 29篇 |
1994年 | 28篇 |
1993年 | 20篇 |
1992年 | 38篇 |
1991年 | 25篇 |
1990年 | 31篇 |
1989年 | 35篇 |
1988年 | 19篇 |
1987年 | 19篇 |
1986年 | 24篇 |
1985年 | 16篇 |
1984年 | 20篇 |
1983年 | 20篇 |
1982年 | 13篇 |
1981年 | 10篇 |
1980年 | 11篇 |
1977年 | 8篇 |
1976年 | 11篇 |
1975年 | 13篇 |
1974年 | 16篇 |
1973年 | 8篇 |
排序方式: 共有5150条查询结果,搜索用时 31 毫秒
71.
Daisuke Kanda Masaaki Miyata Yoshiyuki Ikeda Akihiro Tokushige Takeshi Sonoda Ryo Arikawa Kazuhiro Anzaki Ippei Kosedo Satoshi Yoshino Takuro Takumi Mitsuru Ohishi 《Journal of atherosclerosis and thrombosis》2022,29(6):894
Aim: In this study, we aim to examine the clinical meaning of low-density lipoprotein cholesterol (LDL-C) <70 mg/dL as assessed by Friedewald equation [LDL-C (F)] and Martin method [LDL-C (M)] and non-high-density lipoprotein cholesterol (HDL-C) <100 mg/dL on the occurrence of new lesions among Japanese patients with stable angina who underwent percutaneous coronary intervention (PCI) and were prescribed with strong statins. Methods: Among the 537 consecutive stable angina patients who had underwent PCI and had been prescribed with strong statins, the association between the occurrence of new lesions with myocardial ischemia at the 9-month follow-up coronary angiography and ≤ 2 years after PCI and baseline characteristics were assessed. Results: New lesions appeared 9 months and ≤ 2 years after PCI in 31 and 90 patients, respectively. Multivariate logistic regression analysis revealed diabetes mellitus (DM) was significantly associated with the occurrence of new lesions ≤ 2 years after PCI [odds ratio (OR) 1.71, 95 % confidence interval (CI) 1.06–2.83,p=0.031], and only non-HDL-C ≥ 100 mg/dL was associated with the occurrence of new lesions both at 9 months and ≤ 2 years after PCI [OR 1.80, 95 % CI 1.10–3.00,p=0.021 and OR 1.85, 95 % CI 1.13–3.07,p=0.016]. Conclusions: Non-HDL-C ≥ 100 mg/dL was determined to be the independent risk factor for the occurrence of new lesions 9 months and ≤ 2 years after PCI among stable angina patients with strong statins. Residual risk after PCI should be considered by assessing not only DM but also non-HDL-C beyond the scope of LDL-C-lowering therapy with strong statins. 相似文献
72.
Hiroyuki Inoue Atsushi Shiozaki Hitoshi Fujiwara Hirotaka Konishi Jun Kiuchi Takuma Ohashi Hiroki Shimizu Tomohiro Arita Yusuke Yamamoto Ryo Morimura Yoshiaki Kuriu Hisashi Ikoma Takeshi Kubota Kazuma Okamoto Eigo Otsuji 《Oncology Letters》2022,24(2)
Predicting the prognosis and adverse events (AEs) of nivolumab therapy for recurrent esophageal cancer is very important. The present study investigated whether a simple blood biochemical examination could be used to predict prognosis and AEs following nivolumab treatment for relapse of esophageal cancer. A total of 41 patients who received nivolumab treatment for recurrent esophageal cancer after esophagectomy were analyzed. The absolute lymphocyte count (ALC), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), monocyte-lymphocyte ratio (MLR) and C-reactive protein-albumin ratio (CAR) were assessed at the time of nivolumab induction as indices that can be calculated by blood biochemical examinations alone. Median values were 1,015 for ALC, 3.401 for NLR, 242.6 for PLR, 0.458 for MLR and 0.119 for CAR, and patients were divided into two groups according to values. A high ALC, low NLR, low PLR, low MLR and low CAR were associated with a better response to nivolumab. In addition, patients with the aforementioned indices, with the exception of low PLR, or better response were more likely to develop AEs in univariate analysis. In multivariate analysis, a high ALC [odds ratio (OR): 4.857, P=0.043] and low CAR (OR: 9.099, P=0.004) were identified as independent risk factors for AEs. Survival analysis revealed that overall survival and progression-free survival (PFS) rates after nivolumab treatment differed significantly between the high and low groups of ALC, NLR, PLR, MLR and CAR. The multivariate analysis identified a low ALC [hazard ratio (HR): 3.710, P=0.003] and high CAR (HR: 2.953, P=0.007) as independent poor prognostic factors of PFS. In conclusion, ALC and CAR have potential as biomarkers for outcomes of recurrent esophageal cancer following nivolumab treatment. 相似文献
73.
Hiroshi Kurazumi Ryo Suzuki Ryosuke Nawata Toshiki Yokoyama Sarii Tsubone Yutaro Matsuno Akihito Mikamo Kimikazu Hamano 《Interactive Cardiovascular and Thoracic Surgery》2022,35(1)
OBJECTIVESTo evaluate the feasibility of open chest management with our modified negative pressure wound therapy immediately after cardiac surgery as a therapy for atypical tamponade.METHODSOpen chest with modified negative pressure wound therapy was performed immediately after cardiac surgery. The surface of the heart and the vessels were covered with non-adherent siliconized gauze. The sternal halves were stented using edge-cut disposable syringes to maintain a larger mediastinal cavity. Approximately 45 mm of distance was kept between the sternal edges. A trimmed sterile polyvinyl foam sponge was inserted into the mediastinum, the entire wound was sealed and negative pressure (−50 to −75 mmHg) was applied using a suction generator. Delayed chest closure was performed in a standard manner once the haemodynamic status was stabilizsed.RESULTSThe mortality rate was 3/15 (20%) patients. Deep sternal wound infection occurred in 1/15 (6.7%) patients. Five patients were extubated during the open chest management. Sternal closure was delayed for median of 3 days after the initial surgery. There was no incidence of bleeding complications or need for additional haemostatic procedures.CONCLUSIONSNegative pressure wound therapy performed immediately after cardiac surgery was feasible in our small number of patients.Clinical registration numberStudy ID: 2020-149. 相似文献
74.
Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses 总被引:4,自引:0,他引:4
BACKGROUND: Immune regulatory CD4+CD25+ T (regulatory T; Treg) cells play a vital role in the induction and maintenance of self-tolerance. They are essential for the homeostasis of T cells, the prevention of autoimmunity, and the induction of tolerance to allogeneic donor grafts. However, the underlying mechanism of their functions remains mostly elusive. Therefore, we investigated here a crucial role of Treg cells in their response to alloantigen via the programmed death (PD)-1/PD-1 ligand (PD-L1) pathway. METHODS: In vitro mixed lymphocyte reaction (MLR) assay, graft-versus-host disease (GvHD) and a skin transplantation model were used to evaluate the mechanisms of PD-1/PD-L1 pathway. RESULTS: Blockade of the PD-1/PD-L1 pathway using anti-PD-L1 monoclonal antibodies (mAb) is found to inhibit Treg cell's ability to suppress and restore CD4+CD25-T-cell proliferation in vitro. GvHD was lethal after adoptive transfer of allogeneic C57BL/6 (H-2K) spleen cells to NOD/SCID (H-2K) mice unless CD25+ T cells were also included. Strikingly, the suppression of GvHD by CD25+ cells was abrogated by anti-PD-L1 mAb administration. The abrogation of Treg-cell-mediated suppression could also be demonstrated in a Balb/c (H-2K) to B6/Rag-2KO (H-2K) skin-allograft model. CONCLUSIONS: The blockade of the PD-1/PD-L1 pathway abrogates Treg-mediated immunoregulation, thus suggesting that the PD-1/PD-L1 pathway is required for Treg suppression of the alloreactive responses of CD4+CD25-T cells. This finding has important implications for clarifying the mechanisms of allograft rejection and GvHD. 相似文献
75.
Takagawa R Fujii S Ohta M Nagano Y Kunisaki C Yamagishi S Osada S Ichikawa Y Shimada H 《Annals of surgical oncology》2008,15(12):3433-3439
Background We evaluated the prognostic value of the preoperative serum carcinoembryonic antigen (CEA) level in patients with colorectal
cancer (CRC).
Patients and Methods The study group comprised 638 patients. The optimal cutoff value for the preoperative serum CEA level was determined. Predictive
factors of recurrence were evaluated using multivariate analyses. The relapse-free time was investigated according to the
CEA level.
Results All patients underwent potentially curative resection for CRC without distant metastasis, classified as stage I, II, or III.
The optimal cutoff value for preoperative serum CEA level was 10 ng/ml. Elevated preoperative serum CEA level was observed
in 92 patients. Multivariate analysis identified tumor–node–metastasis (TNM) stage and preoperative serum CEA level as independent
predictive factors of recurrence. The relapse-free survival between CEA levels >10 ng/ml and <10 ng/ml significantly differed
in patients with stage II and III. However, there was no significant difference in relapse-free survival between CEA levels
>10 ng/ml and <10 ng/ml in patients with stage I.
Conclusion Preoperative serum CEA is a reliable predictive factor of recurrence after curative surgery in CRC patients and a useful indicator
of the optimal treatment after resection, particularly for cases classified as stage II or stage III. 相似文献
76.
Chikara Kunisaki Hirochika Makino Ryo Takagawa Kei Sato Mayumi Kawamata Amane Kanazawa Naoto Yamamoto Yasuhiko Nagano Shoichi Fujii Hidetaka A. Ono Hirotoshi Akiyama Hiroshi Shimada 《Surgical endoscopy》2009,23(9):2085-2093
Background Some studies have found high incidences of intraoperative and postoperative complications for patients with gastric cancer.
To determine the predictive factors for the surgical complications of laparoscopic gastric surgery, surgical outcomes were
evaluated.
Methods Between April 2002 and December 2007, 152 patients with preoperatively diagnosed early gastric cancer who underwent laparoscopy-assisted
distal gastrectomy (LADG) were enrolled. Visceral (VFA) and subcutaneous fat areas (SFA) were assessed by Fat Scan software.
The predictive factors for surgical complications of LADG were evaluated by univariate and logistic regression analyses.
Results Of 152 patients, conversion to open surgery due to uncontrollable bleeding was observed in nine male patients, and postoperative
complications were detected in seven male and one female patient (four anastomotic leakage, two intraabdominal abscess, one
pancreatic fistula, and one lymphorrhea). High body mass index (BMI) and high VFA independently predicted conversion to open
surgery and postoperative complications. VFA was significantly higher, operation time was longer, blood loss was greater,
and SFA was lower in male than in female patients, whereas no significant difference was observed in BMI between male and
female patients.
Conclusions High BMI and high VFA can predict technical difficulties during laparoscopic gastric surgery and postoperative complications.
Particularly, LADG should be performed cautiously to prevent surgical complications for male patients with high VFA. Predictive
impact of VFA should be further determined in a larger set of patients. 相似文献
77.
78.
Tomofumi Fujino Akihito Yokosuka Hideaki Higurashi Rina Yokokawa Ryo Sakurai Wataru Harashima Yuichi Miki Yasuyuki Fujiwara Yoshihiro Mimaki Makio Hayakawa 《Journal of natural medicines》2017,71(1):36-43
Here, we show that AU-1, spirostanol saponin isolated from Agavaceae plants, causes a transient increase in cyclin-dependent kinase inhibitor (CDKI) p21/Cip1 through the upregulation of miRNAs, miR-34 and miR-21. AU-1 stimulated p21/Cip1 expression without exerting cytotoxicity against different types of carcinoma cell lines. In renal adenocarcinoma ACHN cells, AU-1 transiently elevated the expression level of p21/Cip1 protein without marked increases in p21/Cip1 mRNA levels. Rapid and transient increases in miR-34 and miR-21, both of which are known to upregulate p21/Cip1, were observed in AU-1-treated cells. Inhibitor for miR-34 and for miR-21 significantly blocked the AU-1-caused increase in p21/Cip1, indicating that elevation of p21/Cip1 protein by AU-1 is dependent on these microRNAs. We further clarified that NAD-dependent deacetylase SIRT1, a direct target of miR-34, is decreased by the treatment with AU-1. Furthermore, we found that SIRT1-knockdown increases p21/Cip1 protein levels in an miR-21-dependent manner. On the other hand, ectopic expression of p21/Cip1 resulted in the lowered expression of miR-34 and miR-21, suggesting that reciprocal regulation exists between p21/Cip1 and these miRNAs. We propose that the following feedback network composed of miR-34/SIRT1/miR-21/p21 is triggered by the treatment with AU-1: in cells treated with AU-1, transient elevation of miR-34 leads to the downregulation of SIRT1, thereby miR-21 is freed from SIRT1-dependent suppression. Then, elevated miR-21 upregulates p21/Cip1 protein, followed by the suppression of miR-34 expression. 相似文献
79.
80.